IDNA vs. SURI ETF Comparison
Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI)
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Grade (RS Rating)
Last Trade
$23.66
Average Daily Volume
30,038
34
SURI
Simplify Exchange Traded Funds Simplify Propel Opportunities ETF
SURI Description
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.Grade (RS Rating)
Last Trade
$23.69
Average Daily Volume
5,487
15
Performance
Period | IDNA | SURI |
---|---|---|
30 Days | -1.43% | 1.36% |
60 Days | -3.01% | 2.75% |
90 Days | -5.37% | 2.33% |
12 Months | 19.24% | 44.62% |
0 Overlapping Holdings
Symbol | Grade | Weight in IDNA | Weight in SURI | Overlap |
---|
IDNA Overweight 34 Positions Relative to SURI
Symbol | Grade | Weight | |
---|---|---|---|
EXEL | B | 6.67% | |
RVMD | C | 5.9% | |
GILD | C | 5.81% | |
BGNE | D | 5.16% | |
INCY | C | 4.99% | |
ACLX | C | 4.09% | |
SRPT | D | 3.75% | |
MRK | F | 3.2% | |
REGN | F | 3.11% | |
SWTX | C | 2.8% | |
TWST | D | 2.72% | |
LGND | B | 2.4% | |
GERN | D | 2.36% | |
IOVA | F | 2.16% | |
BEAM | D | 2.12% | |
DVAX | C | 1.88% | |
BCRX | D | 1.74% | |
BPMC | C | 1.55% | |
NRIX | D | 1.49% | |
NVAX | F | 1.26% | |
MRNA | F | 1.06% | |
CRSP | D | 0.98% | |
IBRX | C | 0.91% | |
RCUS | F | 0.8% | |
VIR | D | 0.72% | |
ARCT | F | 0.49% | |
OABI | F | 0.43% | |
FDMT | F | 0.41% | |
XNCR | B | 0.38% | |
NTLA | F | 0.34% | |
QURE | D | 0.33% | |
DNA | F | 0.27% | |
EDIT | F | 0.23% | |
MGNX | F | 0.22% |
IDNA: Top Represented Industries & Keywords
SURI: Top Represented Industries & Keywords